These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11579680)

  • 41. Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.
    Ooi A; Mai M; Ogino T; Ueda H; Kitamura T; Takahashi Y; Kawahara E; Nakanishi I
    Cancer; 1988 Sep; 62(6):1096-104. PubMed ID: 3044573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
    Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
    Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acinar cell carcinoma of the pancreas in a young patient with cells immunoreactive for somatostatin.
    Rouleau C; Serre I; Roger P; Guibal MP; Galifer RB; Bonardet A; Baldet P
    Histopathology; 2006 Feb; 48(3):307-9. PubMed ID: 16430479
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats.
    Jimenez RE; Z'graggen K; Hartwig W; Graeme-Cook F; Warshaw AL; Fernandez-del Castillo C
    Am J Pathol; 1999 Apr; 154(4):1223-9. PubMed ID: 10233860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report.
    Kos-Kudła B; Zemczak A; Foltyn W; Marek B; Strzelczyk J; Telega A; Zajecki W; Legaszewski T; Jurecka-Lubieniecka B
    Endokrynol Pol; 2007; 58(2):123-9. PubMed ID: 17578828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mixed exocrine-endocrine tumors of the pancreas.
    Klöppel G
    Semin Diagn Pathol; 2000 May; 17(2):104-8. PubMed ID: 10839610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The gastro-enteric-pancreatic neuroendocrine system in two reptilian species: Chalcides chalcides and Zoonosaurus madascariensis (Sauridae).
    Morescalchi AM; Gaccioli M; Faraldi G; Tagliafierro G
    Eur J Histochem; 1997; 41(1):29-40. PubMed ID: 9174843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor.
    Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A
    Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs.
    Kasajima A; Papotti M; Ito W; Brizzi MP; La Salvia A; Rapa I; Tachibana T; Yazdani S; Sasano H; Volante M
    Hum Pathol; 2018 Feb; 72():144-152. PubMed ID: 29180250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
    Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
    Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
    Reubi JC; Waser B; Friess H; Büchler M; Laissue J
    Gut; 1998 Apr; 42(4):546-50. PubMed ID: 9616318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical study of pancreatic neuroendocrine tumor in Panthera tigris tigris.
    Nyska A; Goldstein J; Eshkar G; Klein B
    J Wildl Dis; 1996 Jul; 32(3):541-4. PubMed ID: 8827685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study.
    Taniyama Y; Suzuki T; Mikami Y; Moriya T; Satomi S; Sasano H
    Endocr J; 2005 Oct; 52(5):605-11. PubMed ID: 16284440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.
    Romiti A; Di Rocco R; Milione M; Ruco L; Ziparo V; Zullo A; Duranti E; Sarcina I; Barucca V; D'Antonio C; Marchetti P
    Anticancer Res; 2012 Jan; 32(1):115-9. PubMed ID: 22213295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor-II in endocrine pancreatic tumours. Immunohistochemical, biochemical and in situ hybridization findings.
    Höög A; Kjellman M; Nordqvist AC; Höög CM; Juhlin C; Falkmer S; Schalling M; Grimelius L
    APMIS; 2001 Feb; 109(2):127-40. PubMed ID: 11398994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
    Hayashi H; Ooi A; Nakanishi I
    Jpn J Clin Oncol; 1990 Dec; 20(4):339-48. PubMed ID: 1704442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of islet hormones in human adult pancreatic ducts.
    Li R; Yu L; Zhang X; Zhou X; Wang M; Zhao H
    Digestion; 2015; 91(2):174-9. PubMed ID: 25765455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
    Ferrero S; Buffa R; Pruneri G; Siccardi AG; Pelagi M; Lee AK; Coggi G; Bosari S
    Virchows Arch; 1995; 426(6):587-92. PubMed ID: 7655739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.
    Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R
    Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.